Logo Image
News
All NewsPractice Management
Media
All VideosExpert InterviewsPodcastsMedical World NewsPeer ExchangeInsightsCase StudiesCase of the QuarterClinical ForumsPractice OwnershipRapid ReadoutShortsVideo SeriesWhat’s Your WhEYE?
Conferences
Conference CoverageConference ListingConference Recaps
Blog
More
Publications
Digital EditionSupplements And Featured PublicationsiTech
Partners
Resources
Job BoardSponsored
CE

Subscribe

  • News
  • Media
  • Conferences
  • Blog
  • Publications
  • Partners
  • Resources
  • Subscribe
  • CE
  • AMD
  • Allergy
  • Blepharitis
  • COVID-19
  • Cataract
  • Comanagement
  • Comprehensive Eye Exams
  • Conjunctivitis
  • Contact Lenses
  • Cornea
  • DME
  • Diabetic Eye Disease
  • Dry Eye
  • Geographic Atrophy
  • Glasses
  • Glaucoma
  • LASIK
  • Lens Technology
  • Lid and Lash
  • Myopia
  • Nutrition
  • OCT
  • Ocular Surface Disease
  • Optic Relief
  • Patient Care
  • Pediatrics
  • Presbyopia
  • Ptosis
  • Refractive Surgery
  • Retina
  • Technology
  • Therapeutic Cataract & Refractive
Spotlight -
Geographic Atrophy|
Myopia
Advertisement

Mitchell Jackson, MD

Advertisement

Articles by Mitchell Jackson, MD

ASCRS 2023: Laser scleral microporation from Ace Vision Group

ByMitchell Jackson, MD,Sydney M Crago, Editor, Modern Retina,Sheryl Stevenson
May 19th 2023

Mitchell Jackson, MD, discussed laser scleral microporation from Ace Vision Group at the 2023 ASCRS annual meeting in San Diego.

Advertisement

Latest Updated Articles

  • ASCRS 2023: Laser scleral microporation from Ace Vision Group
    ASCRS 2023: Laser scleral microporation from Ace Vision Group

    May 19th 2023



Advertisement
Advertisement

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

1

CLI study: Contact lens patients significantly more profitable than spectacle-only wearers

2

Orasis Pharmaceuticals, BlinkRx partnership offers new dispensing options for Qlosi

3

New CLI data unveils major profitability potential in contact lenses

4

Detoxifying for visual longevity

5

Glaukos completes enrollment in pivotal trial of Preserflo MicroShunt for treatment-resistant glaucoma

  • Advertise
  • About Us
  • Editorial
  • Contact Us
  • Job Board
  • Terms & Conditions
  • Privacy
  • Do not sell my Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Ophthalmology Times
  • Modern Retina
  • Optometry Times
  • Ophthalmology Times Europe
Collaborative Care Symposium
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us